Related Experiment Video

Updated: May 18, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Protease-activated receptor-4 deficiency does not protect against bleomycin-induced pulmonary fibrosis in mice

Keren Borensztajn1, JanWillem Duitman, Lois W Brüggemann

  • 1Center for Experimental and Molecular Medicine, Academic Medical Center, Room H2-257, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.

The European Respiratory Journal
|October 2, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization02:46

A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization

Published on: January 20, 2023

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on: January 16, 2026

Related Concept Videos